Comparison of Efficacy and Safety of Montelukast Versus Gabapentin in the Treatment of Pruritus, in Patients on Hemodialysis
Keywords:
Hemodialysis, Pruritus, Montelukast.Abstract
Introduction: Patients with end stage renal disease (ESRD), frequently present with intractable pruritus. In the recent past, many newer therapies have emerged for its treatment with variable results. We studied the antipruritic efficacy and safety of Montelukast sodium, (a leukotriene receptor antagonist), and compared it with Gabapentin in patients on hemodialysis. Materials and Methods: The study was conducted in the Department of Dermatology, Sharif Medical and Dental College Lahore. It was a Quasi experimental study, 60 patients on hemodialysis, with refractory pruritus were enrolled in each group .Patients were given 10mg of tab Montelukast sodium daily and 300mg of Gabapentin thrice a week for four weeks. Severity of pruritus was assessed using pruritus scoring by Duo. Results: Pruritus severity score reduced with both the treatments ,but Montelukast showed comparatively higher relief in pruritus score as compared to Gabapentin ( p<0.05). Patients on Gabapentin complained of increased sedation. Conclusions: Montelukast is more effective and safe treatment option for the refractory pruritus in patients with hemodialysis as compared to Gabapentin in our population.
Downloads
Published
How to Cite
Issue
Section
License
The Journal of Fatima Jinnah Medical University follows the Attribution Creative Commons-Non commercial (CC BY-NC) license which allows the users to copy and redistribute the material in any medium or format, remix, transform and build upon the material. The users must give credit to the source and indicate, provide a link to the license, and indicate if changes were made. However, the CC By-NC license restricts the use of material for commercial purposes. For further details about the license please check the Creative Commons website. The editorial board of JFJMU strives hard for the authenticity and accuracy of the material published in the journal. However, findings and statements are views of the authors and do not necessarily represent views of the Editorial Board.